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Abstract 
Background: Malaria is one of the main health problems in the sub‑Saharan Africa accounting for approximately 
198 million morbidity and close to 600,000 mortality cases. Households incur out‑of‑pocket expenditure for treatment 
and lose income as a result of not being able to work or care for family members. The main objective of this survey 
was to assess the economic cost of treating malaria and/or fever with the new ACT to households in the Kintampo 
districts of Ghana where a health and demographic surveillance systems (KHDSS) are set up to document population 
dynamics.
Methods: The study was a cross‑sectional survey conducted from October 2009 to July 2011 using community 
members’ accessed using KHDSS population in the Kintampo area. An estimated sample size of 4226 was randomly 
selected from the active members of the KHDSS. A structured questionnaire was administered to the selected popu‑
lates who reported of fever within the last 2 weeks prior to the visit. Data was collected on treatment‑seeking behav‑
iour, direct and indirect costs of malaria from the patient perspective.
Results: Of the 4226 households selected, 947 households with 1222 household members had fever out of which 
92 % sought treatment outside home; 55 % of these were females. 31.6 % of these patients sought care from chemi‑
cal shops. A mean amount of GHS 4.2 (US$2.76) and GHS 18.0 (US$11.84) were incurred by households as direct 
and indirect cost respectively. On average a household incurred a total cost of GHS 22.2 (US$14.61) per patient per 
episode. Total economic cost was lowest for those in the highest quintile and highest for those in the middle quintile.
Conclusion: The total cost of treating fever/malaria episode is relatively high in the study area considering the pov‑
erty levels in Ghana. The NHIS has positively influenced health‑seeking behaviours and reduced the financial burden 
of seeking care for those that are insured.
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Background
Malaria is one of the main health problems in sub-Saha-
ran Africa [1]. In 2013, there was an estimated 198 mil-
lion cases of malaria with estimated deaths of 584,000 in 
Africa [2]. The annual reported confirmed malaria cases 
in Ghana in 2013 were about 1.6 million out of which 
2506 resulted in deaths. In addition to being respon-
sible for a high rate of morbidity and mortality, malaria 
can lead to impaired cognitive development and learn-
ing abilities [3], school absenteeism [4] and low levels of 
attention at school [5].
Malaria and its associated costs present a major socio-
economic challenge to households in Africa. It leads to 
considerable economic burden at the household level 
and the poorest households in the population are mostly 
affected [6, 7]. Households are affected through out-
of-pocket expenditure for treatment and by the loss of 
income as a result of not being able to work or care for 
family members. Cost of malaria constitutes significant 
shares of annual household incomes ranging from 6 to 
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13  % depending on the burden of malaria [8, 9]. Cost 
of time lost to patients and caretakers as a result of the 
disease constitute more than fifty percent of total cost 
of treating malaria [6, 7]. Loss of working days due to 
malaria by a sick adult in some malaria endemic areas of 
Africa has reported a range between 6–9 days. This leads 
to substantial loss of productive man-hours to house-
holds, resulting in decrease in household income [6, 10–
12]. Malaria in Africa has been reported to cause about 
1.3 % reduction in annual economic growth rate [10, 13, 
14].
WHO recommended treatment of malaria with com-
bination therapy preferably those which contain arte-
misinin [15] for countries suffering from malaria. This is 
because artemisinin-based combination therapy (ACT) 
has been known to be safe and effective with known 
slow emergent resistance by malaria parasites. Ghana 
introduced ACT as the first-line drug for the treatment 
of uncomplicated malaria in 2004 [16]. Though ACT 
is safe and effective compared to monotherapies, it is 
however much more expensive [17]. This survey sought 
to assess the economic cost of treatment-seeking for 
malaria and/or fever with the new ACT to households in 
the Kintampo municipality of Ghana. This study is part 
of INDEPTH Phase IV Safety and Effectiveness Stud-
ies (INESS) carried out between 2009 and 2011 as part 
of assessing the real life determinants of effectiveness of 
new anti-malarials that are introduced after licensure 
[18].
Methods
Study area
Kintampo districts cover an area of approximately bout 
7162  km2 a resident population size of about 150,000 
inhabitants in 29,438 households [19]. Kintampo Health 
Research Center (KHRC) located in the Kintampo dis-
tricts maintains the Kintampo Health and Demographic 
Surveillance System (KHDSS), which was used for sam-
pling households for this study. The KHDSS routinely 
collects demographic information on age, sex, pregnan-
cies, births, deaths, and migrations among others and 
does verbal autopsies to determine the cause of deaths 
[20]. The site also collects data on household assets and 
possessions that enable the assessment of socio-eco-
nomic status of the population. There are two hospitals, 
twenty health centres, three private clinics and five public 
Community Health Planning Services (CHPS) compound 
in the study area. At the time of this study about 50  % 
[21] of inhabitants in the study area had valid National 
Health Insurance cards to access health care in public 
and private accredited by the National Health Insurance 
Authority (NHIA). Currently, health insurance coverage 
is about 66 % [22]. The study area is mainly rural with few 
urban settlements. Farming is the main economic activ-
ity in the area. Malaria accounts for more than half of all 
out-patient visits in the study area [23].
Study design
This was a cost analysis study based on patient’s perspec-
tive. A cross-sectional household survey was conducted 
between October 2009 and September 2011 among com-
munity members in the Kintampo area located in the 
middle part of Ghana.
Participant selection and data collection
Assuming 6  % of the entire inhabitants will have had 
fever in the 2 weeks prior to the day of interview and that 
50 % of them will seek care and have physical access to 
an authorized point of provision of ACT: then with 95 % 
confidence and allowing for 10 % drop-out, the estimated 
sample size of 4226 households will be achieved. House-
holds were randomly selected from the 4226 households 
using the KHDSS household database and interviewed 
with a structured questionnaire. Household members 
who reported of fever within the last 2  weeks prior to 
their interview were included in the survey. However, 
only those who sought treatment outside their homes 
and incurred costs in seeking treatment were included 
in the analysis. Data was obtained from household mem-
bers on socio-demographic characteristics, treatment-
seeking patterns as well as direct and indirect costs of 
seeking treatment outside home.
Data management and analysis
Data was double-entered into Epidata 3.1 (THE EPI-
DATA ASSOCIATION, ODENSE M, DENMARK, 
EUROPE) and transferred to Stata 11.0© (STATA 
CORP. TX) for analysis. The total economic cost of 
fever per household was estimated by summing the 
direct and indirect costs incurred per household. The 
estimated mean and median costs with their respec-
tive 25th and 75th percentiles (iqr) and standard devia-
tions (SD) are presented. Direct costs were defined as 
out-of-pocket expenditure incurred by the households 
as a result of seeking treatment for their fever outside 
their homes. It included cost of self-treatment, medi-
cal costs and non-medical costs. Cost of self-treatment 
comprised the cost of medicines purchased from phar-
macies, chemical and other drug sellers without pre-
scription from a doctor or medical staff at a health 
facility. Medical costs included consultation, laboratory 
and prescription fees incurred at a health facility. Non-
medical cost included cost of transportation to and 
from the facility where care was sought and other non-
medical costs incurred as a result of seeking health care 
for the treatment of fever.
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Indirect cost was defined as the cost of productivity 
losses to households as a result of their fever and inabil-
ity to work. It was calculated as a product of the number 
of days respondents were unable to work and their daily 
wage. Daily wage was estimated in several ways depend-
ing on the type of economic activity the respondent was 
involved. The daily wage for economically active adults 
(defined as persons aged 18 years and above; and engaged 
in informal income generating activities, such as farming) 
who hired others to do their work during the course of 
the fever was calculated as the cost paid out to others to 
get the work done. Among patients who earned monthly 
income, daily wage was estimated as their total monthly 
income divided by 22 days with the assumption that they 
worked 5  days per week for a month of 4  weeks. Stu-
dents were asked to report on the number of school days 
missed due to fever. When adult patients were accompa-
nied by caretakers, the daily wage of their caretaker was 
estimated in a similar manner for the patients. Seeking 
care outside home was defined as seeking care from the 
public or private health facilities, chemist or pharmacist 
and herbalist or drug peddler.
Wealth quintiles for each household were calculated 
using Principal Component Analysis (PCA) and included 
durable households’ possessions such as motorbike, car, 
bed, radio and sewing machine. Information on household 
architecture of material for walls, roofing material, source 
of drinking water, cooking utensils, toilet facility and cook-
ing fuel [24–26] were also obtained. Exchange rate (as at 
30th September 2011): GHS 1.52 is equivalent to $1 [27].
Ethical issues
Written informed consent was obtained from all adult 
participants and from care-takers of children. Addi-
tionally, assent was sought from participants who were 
between 12–18 years. The Kintampo Institutional Ethics 
Committee and the Ghana Health Service Ethical Review 
Committee granted ethical approval for the study.
Results
Socio‑demographic characteristics
Of the 4226 households selected, 947 (22.4  %) house-
holds with 1222 household members reported of having 
fever within the 2 weeks prior to their interview. Ninety-
two percent (1127/1222) sought treatment outside their 
homes and, therefore, met the criteria for inclusion in 
the analysis. More females reported of fever than males 
(Table 1). Fifty-eight percent of the patients were below 
18  years of age. Fifty-four percent and 15.1  % of those 
who reported of fever were farmers and unemployed, 
respectively. About 17.4 % of the respondents were in the 
highest wealth quintile whilst 21.2 % were in the lowest 
wealth quintile (Table 1).
Households’ treatment‑seeking behaviour
Close to 32  % (356/1127) of patients who sought care 
outside their homes did so from chemical shops, 22.7 % 
(256/1127) from hospital, 17.9 % (202/1127) from private 
clinics and less than 5 % from Community based Health 
Planning and Services (CHPS). Majority of respondents 
in the different wealth quintiles sought care from the 
chemical seller shops. Most of the respondents in the 
rich group sought care from the private clinics, as 39 % 
of patients in the highest wealth quintile sought care 
from private clinics compared with only eight percent 
in the middle class who sought care from private clinics. 
Majority of respondents, who sought care from the CHPs 
compounds were from the poorest of the population. 
Respondents who sought care from drug peddlers were 
mostly from the lowest socioeconomic groups (Table 2).
Households mode of payment for cost of fever
Households used different means to pay for the cost of 
fever (Fig. 1). About 48 % of respondents (536/1132) had 
their cost of fever covered by the National Health Insur-
ance Scheme (NHIS); 564 (49.8 %) respondents paid cash 
for the care of fever; a minority of respondents paid for 
their fever through donations, borrowing and sale of 
their assets.
Table 1 Socio-demographic characteristics
Variables Total number Percentage (%)
Had fever and sought care outside 
home
1127 92.2
Response rate
 Consent given 1127 100
Age groups (years)
 <18 658 58.4
 ≥18 469 41.6
Sex
 Male 503 44.6
 Female 624 55.4
Main occupation
 Farmers 255 62.7
 Formal sector 33 8.1
 Traders 84 20.6
 Artisans 25 6.1
 Unemployed 9 2.2
 Other 1 0.3
Wealth quintiles
 Highest 194 17.2
 Fourth 223 19.8
 Middle 278 24.7
 Second 193 17.1
 Lowest 239 21.2
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Days lost due to fever and to productivity
A total of 2020  days with an average of 4.2  days per 
patient was lost due to the reported fever cases (Table 3). 
Sixty-five percent (252/386) of students were not able 
to attend school due to fever leading to a total of 904.4 
school days lost and an average of 2.4 days lost per pupil/
student. For adults, the average number of days lost due 
to fever was highest among farmers (6.4 days) and low-
est among formal sector workers (5.3  days) (Table  3). 
The average number of days lost per patient was highest 
among those who sought care from herbalist (6.9  days) 
and lowest among those who sought care from private 
clinics (3.4 days) (Table 4).
Total cost of treating fever
Total direct cost was found to be GHS 4708.38 (US 
$3097.62) [with a mean cost per fever case of GHS 4.2 
(US$ 2.76)]. Total indirect cost (productivity losses) was 
GHS 20,293.7 (US$ 13,351.12) [with a mean cost per 
fever case of GHS 18.0 (US$ 11.84)]. The overall total 
cost of treating fever for the entire study sample was GHS 
25,002.04 (US$ 16,448.71) [with mean cost per fever case 
of GHS 22.2 (US$ 14.61)]. The highest cost was borne by 
the households who visited hospitals [total cost: GHS 
7702.59 (US$ 5067.49); with mean cost per fever case of 
GHS 34.9 (US$ 22.96)]. Even though the total economic 
cost was lowest for those who visited herbalists [total 
cost: GHS 349 (US$ 229.61)] (Table 5).
Distribution of costs according to wealth quintiles 
showed that the total cost as well as the mean cost per 
participant was lowest for those in the ‘highest’ quin-
tile [total cost: GHS 3868.92; mean cost per fever case: 
GHS19.9 (CI 14.0–25.9)] and highest for those in the 
‘middle’ quintiles [total cost: GHS 6686.28; mean cost per 
fever case: GHS 24.1]. Those in the highest quintile spent 
a lower proportion of their income on cost of fever care 
compared to those in the lowest quintile (Table 6).
Discussion
The overall mean cost of fever was GHS 22.2 ($14.6). 
This is high given that the study area is predominantly 
rural with relatively poor inhabitants. The results also 
showed that the cost was higher for those in the lower 
wealth quintile quintiles compared to those in the higher 
wealth quintiles. This trend can have a number of effects 
on the poor. For example, it can prevent the poor from 
seeking care when they have a fever episode. This is espe-
cially true if they are not members of the NHIS and will 
have to pay out of their pockets for health care. High cost 
combined with out-of-pocket payments can lead to cata-
strophic payments by the poor which can further cause 
the poor to be poorer and also push those above the pov-
erty line into impoverishment [28–30].
The study findings further showed that the cost was 
highest for those who attended hospitals [GHS 30.1]. 
Direct medical cost was identified to form the highest 
component of the direct costs incurred by households 
and this was influenced mostly by the cost of hospitali-
zation. This was probably because patients attended the 
hospitals when their fever was severe and required more 
days for treatment and extensive treatment and services 
Table 2 Treatment-seeking behaviour
Name of provider Number (%) Wealth quintile groupings
Highest (%) Fourth (%) Middle (%) Second (%) Lowest (%)
Chemical seller Shop 356 (31.6) 53 (27.3) 64 (28.7) 109 (39.2) 51 (30.8) 69 (29.7)
CHPs 45 (4.0) 1 (0.5) 9 (4.0) 8 (2.9) 14 (7.3) 13 (5.4)
Private Clinic 202 (17.9) 76 (39.2) 52 (23.3) 23 (8.3) 21 (10.9) 30 (12.6)
Drug peddler 90 (8.0) 0 (0.0) 5 (2.2) 30 (10.8) 40 (20.7) 15 (6.3)
Herbalist 10 (0.9) 2 (1.03) 1 (0.5) 2 (0.7) 4 (2.1) 1 (0.4)
Health Centre 144 (12.8) 5 (2.6) 20 (9.0) 48 (17.3) 25 (13.0) 46 (19.3)
Hospital 256 (22.7) 49 (25.3) 64 (28.7) 56 (20.1) 28 (14.5) 59 (24.7)
Pharmacy 24 (2.1) 8 (4.1) 8 (3.6) 2 (0.7) 2 (1.0) 4 (1.7)
Total 1127 (100) 194 (100) 223 (100) 278 (100) 193 (100) 239 (100)
Fig. 1 Mode of payment of cost of fever
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including hospitalization in most cases. The average 
number of days lost due to fever by patients (4.2  days) 
and days absent from school (2.4 days) were comparable 
to findings from other settings. For instance, in related 
studies in Ghana and Ethiopia [10, 12, 31], the number 
of days lost due to malaria by patients and the lost school 
days ranged between three to nine days [6, 10, 11]. The 
number of days lost, to some extent influenced the pro-
ductivity losses for the respondents. Productivity losses 
are worrying due to the fact that most inhabitants in the 
study area are farmers and peak malaria season coincides 
with the rainy seasons. Days lost to fever affect house-
hold’s productivity and this in effect affects household’s 
income and also the national economy.
Unlike other studies where households mostly borrowed 
money or sold their assets to cover the cost of health care 
[32, 33], the majority of respondents in this study paid for 
care of febrile illness using their health insurance or cash. 
Respondents who paid out-of-pocket were mostly those 
in the lowest quintile. Out-of-pocket payment as a health 
financing mechanism is known to be regressive [34] rather 
than progressive: as poorer households bear a higher bur-
den of the cost compared to the richer households. The 
economic burden of the cost of fever presented in this 
study was higher on those in the lower wealth quintiles 
compared to those in the higher wealth quintiles as they 
used a greater share of their monthly mean income to 
cover the cost of treating their fever.
Household members sought care from different sources 
when they had a fever and majority of the respondents 
sought care from the formal health care facilities (private 
clinics, hospitals, health centres, CHPs compounds) [6, 
35]. The result suggests that treatment-seeking behav-
iour has changed compared to the past decade when 
Table 3 Days lost to productivity by socio-demographic groups
Variables N Total days
 lost
Mean days
 lost
SD Median iqr (25th–75th 
percentile)
Age groups (years)
 <18 40 36 0.9 2.9 0 0
 ≥18 441 1984.5 4.5 4.3 4 0–7.0
Total 481 2020.5 4.2 4.3 3.0 0–7.0
Sex
 Male 167 768.2 4.6 4.4 4.0 0–6.0
 Female 314 1256 4.0 4.2 3.0 0–7.0
Total 481 2024.2 4.2 4.3 3.0 0–7.0
Students 386 937 2.4 2.6 2.0 0–4.0
Main occupation
 Farmer 253 1442.1 5.7 4.2 5.0 3.0–7.0
 Formal sector 27 94.5 3.5 4.1 3.0 0–6.0
 Trader 86 361.2 4.2 4.2 3.0 0–6.0
 Artisans 25 92.5 3.7 4.2 4.0 0–5.0
 Unemployed 9 14.4 1.6 2.5 0 0–2.0
 Other 1 6 6.0 0 6.0 0
Table 4 Choice of provider and days lost to productivity
Variables N Total days  
lost
Mean days  
lost
SD Median iqr (25th–75th 
percentile)
Chemical seller shop 165 644 3.9 4.1 3.0 0–7.0
CHPS 15 58.5 3.9 3.9 3.0 1.0–6.0
Private clinic 92 312.8 3.4 4.1 2.0 0–5.0
Drug peddler 41 168.1 4.1 4.3 3.0 0–7.0
Herbalist 7 48.3 6.9 6.4 3.0 2.0–14
Health centre 40 220 5.5 4.5 5.0 1.5–9
Hospital 108 529.2 4.9 4.3 4.0 0–7.0
Pharmacy 13 48.1 3.7 4.7 2.0 0–4.0
Total 481 2020.2 4.2 4.3 3.0 0–7.0
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households resorted to home treatments [6, 35]. This 
positive trend of care-seeking behaviour can help mini-
mize self-medication and misguided traditional treat-
ment and their associated complications and costs. The 
encouraging trend of seeking care from formal health 
care facilities could be because majority of health facili-
ties are health insurance service providers while com-
munity based licensed chemical sellers are not. It is, 
therefore, anticipated that an increase in the National 
Health Insurance Scheme (NHIS) coverage in the area 
could positively influence households to seek care in for-
mal health care facilities. The positive impact of NHIS on 
formal health care attendance is corroborated in other 
studies [36–38].
Limitations
Despite these findings, there are some limitations to 
this study. Firstly, the study used self-reported fever to 
indicate malaria. Although not all fevers are malaria, in 
Ghana fever is mostly associated with malaria. Secondly, 
Table 5 Direct, indirect and total economic costs of fever
Exchange rate (as at 30th September 2011): $1 is equivalent to GHS 1.52 [27]
Variables Total cost GHS Mean cost per  
patient GHS
SD GHS Median GHS iqr (25th–75th 
percentile) GHS
Direct cost
 All direct cost 4708.4 4.2 10.2 1.5 0.2–4.0
 Medical costs 2110.4 1.9 7.9 0 0
 Non‑medical cost 1596.7 1.4 3.7 0 0–1.9
 Direct cost of self‑treatment 1001.3 0.9 2.4 0 0–1.0
Indirect costs
 All indirect cost 20,293.7 18.0 32.4 8.0 0–21.4
Indirect cost by occupation
 Farmers 6188.6 24.3 23.0 20.0 7.5–35.0
 Formal sector employees 5,54.1 20.5 29.0 5.0 0–40.0
 Traders 4187.4 46.5 70.9 20.5 0–60.0
 Artisans 913.5 36.5 45.2 20.0 0–50.0
 Unemployed 77 8.6 16.2 0 0–10.0
 Under 18 years 8373.1 11.1 19.8 4.0 0–15.0
Total cost 25,002.0 22.2 35.7 11.0 2.0–28.0
Cost by health facility attended
 Chemical shop 6381.6 17.9 29.4 7.6 2.0–24.0
 CHPS 635.1 14.1 15.4 9.6 5.0–15.0
 Clinic 4608.1 22.8 41.8 8.0 0.7–30.0
 Drug peddler 1147.9 12.8 22.3 4.0 1.0–15.0
 Herbalist 349.0 34.9 46.9 12.5 5.0–67.0
 Health centre 3456.4 24.0 31.7 15.0 4.3–30.0
 Hospital 7702.6 30.1 43.0 18.9 5.7–37.4
 Pharmacy 721.8 30.0 48.6 10.8 3.0–30.5
Table 6 Economic burden of fever cost on household’s income
Exchange rate (as at 30th September 2011): GH$1 is equivalent to GHS 1.52 [27]
Wealth quintile 
groupings
Households annual
 monthly income (GHS)
Mean economic cost 
of fever (GHS)
Share of cost on 
income (%)
Highest 3868.9 19.9 13.8
Fourth 4680.0 21.0 19.1
Middle 6686.3 24.1 36.2
Second 4296.8 20.4 31.9
Lowest 5469.5 24.4 54.5
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the costs presented in this study may not be transferable 
to other contexts where health-seeking behaviour, insur-
ance coverage, and occupation differ from those in rural 
Ghana. Finally, there was recall bias as participants were 
asked to recall over a period of 2  weeks. There is possi-
bility of either underestimation or overestimation as they 
reported expenditure verbally without producing receipts.
Conclusion
The total cost of fever episode of GHS 22.2 (US$14.61) 
is quite high considering the poverty level in the middle 
belt of Ghana especially the study setting were majority of 
the households live below the poverty level. The burden 
of fever falls disproportionately on poor households as 
close to five working days are lost due to fever which may 
further push them into poverty. The NHIS has positively 
influenced health-seeking behaviours and reduced the 
financial burden of seeking care to those that are insured.
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